A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease

被引:14
|
作者
Jerkins, Gary [1 ]
Greiner, Jack, V [2 ,3 ]
Tong, Louis [4 ,5 ,6 ]
Tan, Jacqueline [7 ]
Tauber, Joseph [8 ]
Mearza, Ali [9 ,10 ]
Srinivasan, Sruthi [11 ]
机构
[1] Adv Vis Res LLC, Nashville, TN 37205 USA
[2] Clin & & Res Boston, Boston, MA USA
[3] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA
[4] Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore, Singapore
[5] Singapore Eye Res Inst, Singapore, Singapore
[6] Duke Natl Univ, Singapore Med Sch, Singapore, Singapore
[7] Univ New South Wales, Sydney, NSW, Australia
[8] Tauber Eye Ctr, Kansas City, MO USA
[9] Imperial Coll Healthcare NHS Trust, London, England
[10] Ophthalm Consultants London, London, England
[11] Alcon Res LLC, Johns Creek, GA USA
来源
CLINICAL OPHTHALMOLOGY | 2020年 / 14卷
关键词
dry eye; lipid-deficient; evaporative dry eye; lubricant eye drops; non-inferiority; ARTIFICIAL TEARS; MULTICENTER; DEFICIENT; EMULSION; LAYER;
D O I
10.2147/OPTH.S256351
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The aim of this study was to compare the efficacy of two lipid-based lubricant eye drops in patients with lipid-deficient dry eye. Methods: This Phase IV, multicenter, prospective, double-masked study enrolled adults (aged >= 18 years) who had a tear film breakup time (TFBUT) of <= 15 seconds(s), and unanesthetized Schirmer I test of >= 3 mm to <= 12 mm in at least one eye, at both screening and baseline visits. Eligible patients (n=231) were randomized (1:1) and received either Systane (R) Balance (SYSB; n=117) or Refresh (R) Optive Advanced (RFO-Ad, n=114), four-times a day, for 35 days. The primary endpoint was non-inferiority for change from baseline in TFBUT at Day 35 (noninferiority was established if the lower limit of the 95% confidence interval (CI) for the difference between the treatment groups was > -1.0 s); secondary endpoints (test of superiority) were change in TFBUTand global ocular discomfort visual analog scale (VAS) score at Day 35. Other endpoints included the impact of dry eye on everyday life (IDEEL) treatment satisfaction scores (inconvenience and effectiveness) and safety. Results: At Day 35, themean change from baseline in TFBUTwas 0.998 s in the SYSB and 0.868 s in the RFO-Ad groups with a treatment difference: 0.130 s; (95% CI -0.34, 0.60; P<0.0001) demonstrating non-inferiority of SYSB to RFO-Ad. The global ocular discomfort VAS scores improved in both groups, with a mean change from baseline of -9.7 and -8.8 in SYSB and RFOAd groups (treatment difference -0.8; P=0.62), respectively. No meaningful difference was observed in IDEEL treatment effectiveness and treatment inconvenience scores between SYSB vs RFO-Ad (P>0.05 for treatment difference). Both treatments were well tolerated. Conclusion: SYSB lubricant eye drops were non-inferior to RFO-Ad for improvement in TFBUT in patients with lipid-deficient dry eye. Both lubricant eye drops improved TFBUT and ocular discomfort scores in patients with lipid-deficient dry eye.
引用
收藏
页码:1665 / 1673
页数:9
相关论文
共 50 条
  • [21] Comparison of efficacy of trehalose-based eye drops versus topical 0.1% Hyaluronic Acid for management of clinically significant dry eye using non-invasive investigational modalities
    Brar, Sheetal
    Vanga, Hemanth Reddy
    Ganesh, Sri
    INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (10) : 3349 - 3359
  • [22] Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study
    Bickle, Katherine
    Miller, Jason R.
    Tauber, Joseph
    Awisi-Gyau, Deborah
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (02) : 481 - 494
  • [23] Comparison of efficacy of trehalose-based eye drops versus topical 0.1% Hyaluronic Acid for management of clinically significant dry eye using non-invasive investigational modalities
    Sheetal Brar
    Hemanth Reddy Vanga
    Sri Ganesh
    International Ophthalmology, 2021, 41 : 3349 - 3359
  • [24] Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre
    Jain, Kalpna
    Jaju, Meenu
    Yadav, Dinesh
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (04) : 1598 - 1602
  • [25] Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study
    Robert, Pierre-Yves
    Cochener, Beatrice
    Amrane, Mourad
    Ismail, Dahlia
    Garrigue, Jean-Sebastien
    Pisella, Pierre-Jean
    Baudouin, Christophe
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (06) : 546 - 555
  • [26] Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study
    Katherine Bickle
    Jason R. Miller
    Joseph Tauber
    Deborah Awisi-Gyau
    Ophthalmology and Therapy, 2024, 13 : 481 - 494
  • [27] Efficacy and Safety of Houttuynia Eye Drops Atomization Treatment for Meibomian Gland Dysfunction-Related Dry Eye Disease: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
    Liu, Zhaolin
    Jin, Ming
    Li, Ying
    Liu, Jun
    Xiao, Xianghua
    Bi, Hongsheng
    Pan, Zhiqiang
    Shi, Huijun
    Xie, Xiaofeng
    Zhang, Minglian
    Gao, Xuemin
    Li, Lei
    Ouyang, Weijie
    Tang, Liying
    Wu, Jieli
    Yang, Yiran
    Hu, Jiaoyue
    Liu, Zuguo
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 14
  • [28] Efficacy and Safety of Perfluorohexyloctane in Evaporative Dry Eye Disease Associated With Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Guedes, Jaime
    Hespanhol, Larissa C.
    Freitas, Marcos A. A.
    Balieiro, Caroline C. A.
    Souza, Maria Eduarda C.
    Faneli, Adriano Cypriano
    Melo, Hosanna S. S.
    Mora-Paez, Denisse J.
    Fontes, Bruno M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [29] A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease
    Tauber, Joseph
    Wirta, David L.
    Sall, Kenneth
    Majmudar, Parag A.
    Willen, Daniela
    Kroesser, Sonja
    CORNEA, 2021, 40 (09) : 1132 - 1140
  • [30] Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease
    Benitez-Del-Castillo, Jose Manuel
    Moreno-Montanes, Javier
    Jimenez-Alfaro, Ignacio
    Munoz-Negrete, Francisco Jose
    Turman, Krista
    Palumaa, Kadi
    Sadaba, Belen
    Gonzalez, Maria Victoria
    Ruz, Veronica
    Vargas, Beatriz
    Paneda, Covadonga
    Martinez, Tamara
    Bleau, Anne-Marie
    Jimenez, Ana Isabel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (14) : 6447 - 6454